mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.01 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.01 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |